September 2024
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Societies

Inside WCLC24 – Recap by Estela Rodriguez

Photo from Estela Rodriguez/X

Sep 9, 2024, 11:35

Inside WCLC24 – Recap by Estela Rodriguez

The WCLC24 is taking place at the San Diego Convention Center from September 7 to 10, 2024.

Organized by the International Association for the Study of Lung Cancer (IASLC), this major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.

Estela (Estelamari) Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, shared a few highlights from the conference:

My Ribbon is Better than Yours

Power Posing with my super long name badge with creative ribbons.

My favorite ribbons: “Happy to Mentor” and “My Ribbon is Better than Yours”.

Advancements in Oncology SCLC session

Getting ready to speak with Oncology Brothers and Eric K. Singhi on Advancements in Oncology SCLC session.

Grateful for the sisterhood and mentorship of HOWPG

Enjoying an amazing view of San Diego with this amazing Women in Thoracic Oncology Narjust Florez and Jarushka Naidoo.

Grateful for the sisterhood and mentorship/ sponsorship of Hematology & Oncology Women Physicians Group.

Highlighting Plenary Abstract on patient level analysis of CM77T and CM816

Oncology Brothers conversation with Charu Aggarwal and Rami Manochakian on Early Stage Lung Cancer – addressing perioperative vs adjuvant controversy- highlighting Plenary Abstract on patient level analysis of CM77T and CM816 by Patrick Forde.

Balancing toxicity with efficacy and patient’s goals

Great conversation with Narjust Florez and Jarushka Naidoo and Oncology Brothers on management of patients with NSCLC and actionable mutations-

Balancing toxicity with efficacy and patient’s goals.

When in San Diego every day is a day.

Enjoying tacos with our Sylvester Comprehensive Cancer Center Thoracic Research Working Group trainees.

50 Years of IASLC

Celebrating 50 years of IASLC building community, friendships, collaboration to advance lung cancer research.

Estela (Estelamari) Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials.

For more updates on WCLC24, visit oncodaily.com.